CA2826738A1 - Sequences de polynucleotides et de polypeptides impliquees dans le cancer - Google Patents

Sequences de polynucleotides et de polypeptides impliquees dans le cancer Download PDF

Info

Publication number
CA2826738A1
CA2826738A1 CA2826738A CA2826738A CA2826738A1 CA 2826738 A1 CA2826738 A1 CA 2826738A1 CA 2826738 A CA2826738 A CA 2826738A CA 2826738 A CA2826738 A CA 2826738A CA 2826738 A1 CA2826738 A1 CA 2826738A1
Authority
CA
Canada
Prior art keywords
cell
seq
polypeptide
cancer
ovarian cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2826738A
Other languages
English (en)
Inventor
Roy Rabindranauth Sooknanan
Gilles Bernard Tremblay
Mario Filion
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alethia Biotherapeutics Inc
Original Assignee
Alethia Biotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alethia Biotherapeutics Inc filed Critical Alethia Biotherapeutics Inc
Priority claimed from CA2655933A external-priority patent/CA2655933C/fr
Publication of CA2826738A1 publication Critical patent/CA2826738A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
CA2826738A 2006-06-23 2007-06-22 Sequences de polynucleotides et de polypeptides impliquees dans le cancer Abandoned CA2826738A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US81582906P 2006-06-23 2006-06-23
US60/815,829 2006-06-23
US87447106P 2006-12-13 2006-12-13
US60/874,471 2006-12-13
CA2655933A CA2655933C (fr) 2006-06-23 2007-06-22 Sequences de polynucleotides et de polypeptides impliquees dans le cancer

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2655933A Division CA2655933C (fr) 2006-06-23 2007-06-22 Sequences de polynucleotides et de polypeptides impliquees dans le cancer

Publications (1)

Publication Number Publication Date
CA2826738A1 true CA2826738A1 (fr) 2007-12-27

Family

ID=49253625

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2826738A Abandoned CA2826738A1 (fr) 2006-06-23 2007-06-22 Sequences de polynucleotides et de polypeptides impliquees dans le cancer

Country Status (1)

Country Link
CA (1) CA2826738A1 (fr)

Similar Documents

Publication Publication Date Title
US20180346563A1 (en) Polynucleotides and polypeptide sequences involved in cancer
WO2005084109A2 (fr) Gène mh15 spécifique de cancer
EP2362908A1 (fr) Anticorps qui bloquent spécifiquement l'activité biologique d'un antigène tumoral
TW200920406A (en) EBI3, DLX5, NPTX1 and CDKN3 for target genes of lung cancer therapy and diagnosis
US8444975B2 (en) Method for inhibiting bone resorption
US20120128661A1 (en) Polynucleotide and polypeptide sequences involved in cancer
CA2826738A1 (fr) Sequences de polynucleotides et de polypeptides impliquees dans le cancer
US20110286924A1 (en) Novel human endogenous retroviral erv3 variant and uses thereof in the diagnosing ovarian cancer
CA2773614A1 (fr) Procede de traitement du cancer par inhibition de l'expression ou l'activite de trim59
KR101115449B1 (ko) 대장암 진단용 조성물 및 그 용도
KR101115441B1 (ko) 대장암 진단용 조성물 및 그 용도
KR101115443B1 (ko) 대장암 진단용 조성물 및 그 용도
KR101115448B1 (ko) 대장암 진단용 조성물 및 그 용도

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20130905

FZDE Dead

Effective date: 20150702